Onchomycosis, which 35 million Americans have (and most will probably deny), is difficult to treat because the infection is under and inside the nail. Traditional treatments include expensive oral medications (with a risk of liver-related side effects), topically applied medication, and surgery to remove the nail.
Now, PinPointe USA, Inc. (Chico, CA), has recieved FDA clearance for its FootLaser, which penetrates the nail bed, targeting the fungi responsible for the condition while leaving the nail and surrounding healthy tissue intact. PinPointe submitted evidence to the FDA showing that after a single treatment, between 68 and 81 percent of patients experienced increased clear nail at six and 12 months. The treatment lasts 30 minutes and is done without anesthesia.
“Toenail fungus is an incredibly embarrassing chronic condition affecting millions of people world-wide that genuinely affects a person’s quality of life. For some with diabetes or autoimmune disorders nail fungus can lead to serious health problems,” said Dr. Adam Landsman, Assistant Professor of Surgery at Harvard Medical School and Chief of the Division of Podiatric Surgery at Cambridge Hospital in Massachusetts. “With the clearance of the PinPointe FootLaser, patients finally have a pain-free treatment option that is more successful than topically-applied antifungal drugs, safer than oral medication, and less painful than surgical removal of the nail.”